| Literature DB >> 30871604 |
Chonlada Mano1, Narissara Jariyapan2, Sriwatapron Sor-Suwan3, Sittiruk Roytrakul4, Suthathip Kittisenachai4, Pongsri Tippawangkosol5, Pradya Somboon5.
Abstract
BACKGROUND: A group of insecticides called pyrethroids has been used extensively worldwide and development of pyrethroid resistance within mosquito populations, especially in Aedes aegypti, has rapidly spread through populations. In this study, SDS-PAGE, 2-DE coupled with NanoLC-MS, and bioinformatics were used to analyze the female salivary gland proteins of pyrethroid-susceptible (PMD) and pyrethroid-resistant (PMD-R and UPK-R) strains of Ae. aegypti mosquitoes for the first time.Entities:
Keywords: Aedes aegypti; Insecticide resistance; Mosquito salivary proteins; Pyrethroids; Salivary glands
Mesh:
Substances:
Year: 2019 PMID: 30871604 PMCID: PMC6419353 DOI: 10.1186/s13071-019-3374-2
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Insecticide susceptibility status of Ae. aegypti PMD, PMD-R and UPK-R strains
| Strain | Insecticide | Total no. of tested mosquitoes | Total no. of mosquito deaths | Mortality rate (%) | Statusa |
|---|---|---|---|---|---|
| PMD | Permethrin | 300 | 300 | 100 | S |
| Deltamethrin | 300 | 300 | 100 | S | |
| PMD-R | Permethrin | 300 | 40 | 13.33 | R |
| Deltamethrin | 300 | 300 | 100 | S | |
| UPK-R | Permethrin | 300 | 0 | 0 | R |
| Deltamethrin | 300 | 5 | 1.67 | R |
aInterpretation of mortality rate (WHO, 2013)
Abbreviations: R, resistance; S, susceptibility
Fig. 1Electrophoretic protein profiles of salivary glands obtained from female Ae. aegypti mosquitoes of PMD, PMD-R, and UPK-R strains. Proteins of five pairs of salivary glands were separated on a 15% SDS polyacrylamide gel and stained with CBB. Molecular mass markers are indicated on the right in kDa. Arrows indicate major protein bands similarly expressed among the three strains. The arrowhead indicates a protein band observed only in the PMD strain
Fig. 2Comparison of representative 2-DE protein profiles from 60 female salivary glands of Ae. aegypti mosquitoes. a PMD, b PMD-R and c UPK-R strains. Proteins were separated in the first dimension by IEF using a 7 cm strip, pH 3–10. Separation in the second dimension was performed using 15% SDS-PAGE followed by CBB staining. Molecular mass markers are indicated on the left in kDa. Isoelectric points (pI) are indicated at the top. Numbers indicate major spots found in all three strains. Letters (A1-A5) indicate major spots found specifically in each strain
A list of identified female salivary gland proteins of Ae. aegypti PMD, PMD-R, and UPK-R strains by NanoLC-MS analysis
| SNa (MW/pI) | Strain | Accession numberb | Protein description | Prot. scorec | PSd | No. P/ %Ce | Database MW/pI | Peptide sequence(s) | Gene namef |
|---|---|---|---|---|---|---|---|---|---|
| 1 (75/5.3) | PMD | XP_011493320 | AAEL017349-PA | 65 | 36 | 2/3 | 72.4/5.1 | R.LTPEDIER.M | AAEL017349-PA |
| 29 | K.VADDDKATMEEAIDEK.I + Oxidation (M) | ||||||||
| PMD-R | XP_011493320 | AAEL017349-PA | 65 | 36 | 2/3 | 72.4/5.1 | R.LTPEDIER.M | AAEL017349-PA | |
| 29 | K.VADDDKATMEEAIDEK.I + Oxidation (M) | ||||||||
| UPK-R | XP_011493320 | AAEL017349-PA | 271 | 66 | 4/7 | 72.4/5.1 | K.IVITNDQNR.L | AAEL017349-PA | |
| 71 | K.FEELNMDLFR.S + Oxidation (M) | ||||||||
| 63 | K.DVDEIVLVGGSTR.I | ||||||||
| 75 | K.VFAPEEISAMVLGK.M + Oxidation (M) | ||||||||
| 2 (73/5.6) | PMD | ABF18332 | Heat-shock cognate 70 | 40 | 40 | 1/1 | 71.4/5.3 | K.VEIIANDQGNR.T | nag |
| PMD-R | ABF18332 | Heat-shock cognate 70 | 49 | 49 | 1/1 | 71.4/5.3 | K.VEIIANDQGNR.T | na | |
| UPK-R | ABF18332 | Heat-shock cognate 70 | 163 | 80 | 2/3 | 71.4/5.3 | K.DAGTISGLNVLR.I | na | |
| 83 | R.FEELNADLFR.S | ||||||||
| 3 (72/6.2) | PMD | AAL76020 | Putative secreted protein | 84 | 84 | 1/1 | 66.6/5.8 | K.TASNDCTPFR.L | AAEL000748 |
| PMD-R | AAL76020 | Putative secreted protein | 84 | 84 | 1/1 | 66.6/5.8 | K.TASNDCTPFR.L | AAEL000748 | |
| UPK-R | AAL76020 | Putative secreted protein | 130 | 62 | 2/4 | 66.6/5.8 | K.DLEGITDELGK.V | AAEL000748 | |
| 67 | K.DIATLEQNVNTLHK.D | ||||||||
| 4 (69/8.5) | PMD | AAC37218 | Apyrase | 231 | 65 | 3/6 | 63.2/8.5 | R.TGPLDSDVFK.N | APY |
| 82 | K.VTLSNAVEAVR.R | ||||||||
| 84 | K.VEAIGSTVVGETK.I | ||||||||
| PMD-R | AAC37218 | Apyrase | 449 | 66 | 6/12 | 63.2/8.5 | R.TGPLDSDVFK.N | APY | |
| 61 | R.TNCLQVSGLR.I | ||||||||
| 76 | K.VTLSNAVEAVR.R | ||||||||
| 73 | K.VEAIGSTVVGETK.I | ||||||||
| 96 | K.KIEVMDYTNPK.S + Oxidation (M) | ||||||||
| 80 | K.DKVEGPYPTIVESK.N | ||||||||
| UPK-R | AAC37218 | Apyrase | 231 | 81 | 3/5 | 63.2/8.5 | K.IGIIGVLYDK.T | APY | |
| 72 | R.IVIDISKPIR.S | ||||||||
| 78 | K.VTLSNAVEAVR.R | ||||||||
| 5 (68/8.9) | PMD | AAC37218 | Apyrase | 137 | 59 | 2/4 | 63.2/8.5 | R.TNCLQVSGLR.I | APY |
| 75 | K.VEAIGSTVVGETK.I | ||||||||
| PMD-R | AAC37218 | Apyrase | 531 | 66 | 7/12 | 63.2/8.5 | R.TGPLDSDVFK.N | APY | |
| 71 | K.IGIIGVLYDK.T | ||||||||
| 69 | R.TNCLQVSGLR.I | ||||||||
| 87 | K.VTLSNAVEAVR.R | ||||||||
| 68 | R.RTGPLDSDVFK.N | ||||||||
| 79 | K.VEAIGSTVVGETK.I | ||||||||
| 93 | K.DKVEGPYPTIVESK.N | ||||||||
| UPK-R | AAC37218 | Apyrase | 641 | 61 | 9/17 | 63.2/8.5 | R.TGPLDSDVFK.N | APY | |
| 81 | K.IGIIGVLYDK.T | ||||||||
| 64 | R.TNCLQVSGLR.I | ||||||||
| 70 | R.IVIDISKPIR.S | ||||||||
| 79 | K.VTLSNAVEAVR.R | ||||||||
| 59 | K.GLAPYLAELNK.E | ||||||||
| 60 | K.VEAIGSTVVGETK.I | ||||||||
| 80 | K.KIEVMDYTNPK.S + Oxidation (M) | ||||||||
| 63 | K.DKVEGPYPTIVESK.N | ||||||||
| 6 (68/9.5) | PMD | XP_001651903 | AAEL006333-PA | 139 | 80 | 2/3 | 63.9/8.7 | R.ISLAAGAITR.G | AAEL006333 |
| 61 | K.LELSNDCR.L | ||||||||
| PMD-R | XP_001651903 | AAEL006333-PA | 139 | 80 | 2/3 | 63.9/8.7 | R.ISLAAGAITR.G | AAEL006333 | |
| 61 | K.LELSNDCR.L | ||||||||
| UPK-R | ABF18486 | 5’-nucleotidase | 96 | 20 | 3/6 | 61.8/8.9 | R.VTVLGSTIK.K | AAEL006333 | |
| 38 | K.VGESKLELSNDCR.L | ||||||||
| 39 | R.GQILTALPFNSNANR.V | ||||||||
| 7 (66/7.2) | PMD | XP_001651237 | AAEL005672-PA | 593 | 37 | 11/23 | 59.9/6.4 | R.LKLEEMVK.G + Oxidation (M) | AAEL005672 |
| 48 | R.HIFEVLDR.F | ||||||||
| 45 | R.FATDDEFLK.I | ||||||||
| 35 | K.SNHPEFIGAK.F | ||||||||
| 51 | K.EWSLVSEIR.Q | ||||||||
| 51 | R.SLLEFAPALLK.L | ||||||||
| 52 | K.GDFGVSHGPQFK.C | ||||||||
| 70 | R.GVLPDVYDLDGK.I | ||||||||
| 87 | K.TDQNLIDAVLLGSK.R | ||||||||
| 62 | K.QFYDDHVQYLEFR.G | ||||||||
| 54 | K.QLALNSIEYSAMNSEEK.T + Oxidation (M) | ||||||||
| PMD-R | AAL76033 | Putative adenosine deaminase | 100 | 22 | 3/4 | 60.6/6.5 | K.FIYAPGR.F | AAEL005672 | |
| 36 | K.SSHPEFIGAK.F | ||||||||
| 45 | R.FATDDEFLK.I | ||||||||
| UPK-R | AAL76033 | Putative adenosine deaminase | 219 | 70 | 3/7 | 60.6/6.5 | R.GVLPDVYDLDGK.I | AAEL005672 | |
| 87 | K.TDQNLIDAVLLGSK.R | ||||||||
| 62 | K.QFYDDHVQYLEFR.G | ||||||||
| 8 (62/5.1) | PMD | XP_001649774 | AAEL000641-PA | 163 | 77 | 2/4 | 56.3/5.0 | K.MDATANELEHTK.I + Oxidation (M) | AAEL000641 |
| 86 | K.VDATEEQELSEK.H | ||||||||
| PMD-R | XP_001649774 | AAEL000641-PA | 47 | 47 | 1/2 | 56.3/5.0 | R.NGTPIEYTGGR.E | AAEL000641 | |
| UPK-R | XP_001649774 | AAEL000641-PA | 82 | 82 | 1/2 | 56.3/5.0 | K.VDATEEQELSEK.H | AAEL000641 | |
| 9 (59/6.6) | PMD | ABF18028 | Salivary anti-FXa serpin | 121 | 59 | 2/5 | 48.3/6.1 | R.MGQVINDALK.N + Oxidation (M) | SRPN23 |
| 62 | K.TPPEAAMGLEDK.Q + Oxidation (M) | ||||||||
| PMD-R | ABF18028 | Salivary anti-FXa serpin | 58 | 58 | 1/2 | 48.3/6.1 | R.TAMAVAIGSEK.V + Oxidation (M) | SRPN23 | |
| UPK-R | ABF18028 | Salivary anti- FXa serpin | 307 | 59 | 4/11 | 48.3/6.1 | R.TAMAVAIGSEK.V + Oxidation (M) | SRPN23 | |
| 77 | R.MGQVINDALK.N + Oxidation (M) | ||||||||
| 106 | R.IPQFGLQTTVPGR.Q | ||||||||
| 64 | K.VFEQGQDVALGEIVQK.M | ||||||||
| 10 (49/5.1) | PMD | AAL76010 | Putative purine hydrolase | 48 | 48 | 1/2 | 38.2/5.0 | R.QMVEDLNR.- + Oxidation (M) | AAEL006485 |
| PMD-R | AAL76010 | Putative purine hydrolase | 76 | 42 | 2/4 | 38.2/5.0 | R.LITPAPR.R | AAEL006485 | |
| 34 | R.QMVEDLNR.- + Oxidation (M) | ||||||||
| UPK-R | AAL76010 | Putative purine hydrolase | 73 | 73 | 1/3 | 38.2/5.0 | K.SEIAGIYILGGNR.N | AAEL006485 | |
| 11 (48/6.0) | PMD | ABF18025 | Angiopoietin-like protein variant, partial | 68 | 22 | 2/6 | 33.5/5.7 | K.FVVGPEEQR.Y | AAEL000749 |
| 45 | K.FSDVSNTPLK.L | ||||||||
| PMD-R | AAL76032 | Angiopoietin-like protein | 68 | 22 | 2/6 | 33.5/5.7 | K.FVVGPEEQR.Y | AAEL000749 | |
| 45 | K.FSDVSNTPLK.L | ||||||||
| UPK-R | ABF18025 | Angiopoietin-like protein variant, partial | 153 | 37 | 4/15 | 33.5/5.7 | K.FVVGPEEQR.Y | AAEL000749 | |
| 32 | K.FSDVSNTPLK.L | ||||||||
| 35 | K.SSGLTTIPIGSEPR.V | ||||||||
| 49 | R.FTQMFSQQFYR.H + Oxidation (M) | ||||||||
| 12 (45/5.8) | PMD | ABF18018 | Putative 34 kDa secreted protein | 64 | 64 | 1/3 | 36.4/5.2 | K.LQEEIEEQTK.Q | AAEL003601 |
| PMD-R | ABF18018 | Putative 34 kDa secreted protein | 64 | 64 | 1/3 | 36.4/5.2 | K.LQEEIEEQTK.Q | AAEL003601 | |
| UPK-R | ABF18018 | Putative 34 kDa secreted protein | 132 | 65 | 2/6 | 36.4/5.2 | K.SVATEIVQMR.D + Oxidation (M) | AAEL003601 | |
| 68 | K.QNFEDQVNQIVK.S | ||||||||
| 13 (46/5.7) | PMD | AAL76018 | Putative 34 kDa secreted protein | 54 | 54 | 1/4 | 36.4/5.2 | R.DSAISTDQVDQLK.Q | AAEL003601 |
| PMD-R | AAL76018 | Putative 34 kDa secreted protein | 155 | 74 | 2/7 | 36.4/5.2 | R.DSAISTDQVDQLK.Q | AAEL003601 | |
| 81 | K.QNFEDQVNQIVK.S | ||||||||
| UPK-R | AAL76018 | Putative 34 kDa secreted protein | 176 | 40 | 4/12 | 36.4/5.2 | R.IYLGALR.F | AAEL003601 | |
| 54 | K.SVATEIVQMR.D + Oxidation (M) | ||||||||
| 51 | K.VTELEQQIAK.Q | ||||||||
| 35 | K.QNFEDQVNQIVK.S | ||||||||
| 14 (43/6.2) | PMD | ABF18017 | Putative 34 kDa family secreted salivary protein | 98 | 49 | 2/6 | 36.0/6.1 | K.LQEEIEEQTK.Q | AAEL003600 |
| 53 | K.QCNLSEDDLTK.L | ||||||||
| PMD-R | ABF18017 | Putative 34 kDa family secreted salivary protein | 206 | 73 | 3/12 | 36.0/6.1 | K.QCNLSEDDLTK.L | AAEL003600 | |
| 75 | K.TQGVSNMEVQLLR.E + Oxidation (M) | ||||||||
| 60 | R.QANQDTSKAEGEMVEK.I + Oxidation (M) | ||||||||
| UPK-R | ABF18017 | Putative 34 kDa family secreted salivary protein | 256 | 66 | 3/8 | 36.0/6.1 | K.VLNTILDQVNK.L | AAEL003600 | |
| 86 | R.KVLNTILDQVNK.L | ||||||||
| 106 | K.TQGVSNMEVQLLR.E | ||||||||
| 15 (40/9.5) | PMD | AAL16049 | Long form D7Bclu1 salivary protein | 450 | 64 | 6/18 | 39.2/9.4 | K.NELDVDEIAR.D | AAEL006417 |
| 93 | R.SKDYFAALTGK.L | ||||||||
| 74 | K.SSSCSEVFEAFK.K | ||||||||
| 75 | R.KQVDDIDKIQCS.- | ||||||||
| 63 | K.SSSCSEVFEAFKK.V | ||||||||
| 84 | K.LEPSDDQATQCYTK.C | ||||||||
| PMD-R | XP_001657778 | AAEL006417-PA | 614 | 58 | 8/29 | 39.2/9.4 | K.IGFYEPGEKR.F | AAEL006417 | |
| 91 | R.SKDYFAALTGK.L | ||||||||
| 68 | K.YQMGSGIVFER.H + Oxidation (M) | ||||||||
| 83 | K.SSSCSEVFEAFK.K | ||||||||
| 72 | R.KQVDDIDKIQCS.- | ||||||||
| 68 | K.VTNDFKEAFDYR.E | ||||||||
| 88 | K.LEPSDDQATQCYTK.C | ||||||||
| 88 | R.YMTSKNELDVDEIAR.D + Oxidation (M) | ||||||||
| UPK-R | AAL16049 | Long form D7Bclu1 salivary protein | 385 | 63 | 5/14 | 39.2/9.4 | K.AALQNWLGWK.L | AAEL006417 | |
| 82 | R.SKDYFAALTGK.L | ||||||||
| 87 | K.SSSCSEVFEAFK.K | ||||||||
| 60 | K.SSSCSEVFEAFKK.V | ||||||||
| 94 | K.LEPSDDQATQCYTK.C | ||||||||
| 16 (39/9.5) | PMD | AAA29347 | D7 protein | 437 | 72 | 6/21 | 37.6/8.4 | K.SKVEAYANAVK.Q | D7 |
| 71 | K.FDASVIQEQFK.A | ||||||||
| 58 | R.QYTVLDDALFK.E | ||||||||
| 75 | K.DNQLDVEEVKR.D | ||||||||
| 85 | K.CLVESSVKDDFK.E | ||||||||
| 83 | R.CMEDNLEDGANR.L + Oxidation (M) | ||||||||
| PMD-R | AAA29347 | D7 protein | 363 | 66 | 5/17 | 37.6/8.4 | K.SKVEAYANAVK.Q | D7 | |
| 60 | K.DDFKEAFDYR.E | ||||||||
| 69 | K.FDASVIQEQFK.A | ||||||||
| 72 | K.QSYFEFCENK.Y | ||||||||
| 102 | K.QLPSTNNDCAAVFK.A | ||||||||
| UPK-R | AAA29347 | D7 protein | 390 | 61 | 6/21 | 37.6/8.4 | R.TGLYDPVAQK.F | D7 | |
| 68 | K.SKVEAYANAVK.Q | ||||||||
| 71 | K.FDASVIQEQFK.A | ||||||||
| 67 | R.QYTVLDDALFK.E | ||||||||
| 63 | K.DNQLDVEEVKR.D | ||||||||
| 70 | K.QLPSTNNDCAAVFK.A | ||||||||
| 17 (40/8.9) | PMD | AAA29348 | D7 protein | 153 | 55 | 3/9 | 37.5/8.5 | R.TGLYDPVAQK.F | D7 |
| 75 | K.NNELDAEEVKR.D | ||||||||
| 23 | K.KSYFEFCENK.Y | ||||||||
| PMD-R | AAA29348 | D7 protein | 191 | 65 | 3/10 | 37.5/8.5 | K.FDASVIQEQFK.A | D7 | |
| 71 | R.QYTVLDDALFK.E | ||||||||
| 59 | K.NNELDAEEVKR.D | ||||||||
| UPK-R | AAA29347 | D7 protein | 223 | 67 | 3/10 | 37.6/8.4 | R.QYTVLDDALFK.E | D7 | |
| 84 | K.DNQLDVEEVKR.D | ||||||||
| 76 | K.CLVESSVKDDFK.E | ||||||||
| 18 (42/8.9) | PMD | AAA29348 | D7 protein | 75 | 75 | 1/3 | 37.5/8.5 | K.NNELDAEEVKR.D | D7 |
| PMD-R | AAA29348 | D7 protein | 208 | 63 | 3/9 | 37.5/8.5 | K.DDFKEAFDYR.E | D7 | |
| 73 | K.FDASVIQEQFK.A | ||||||||
| 74 | K.KSYFEFCENK.Y | ||||||||
| UPK-R | AAA29348 | D7 protein | 211 | 74 | 3/9 | 37.5/8.5 | K.FDASVIQEQFK.A | D7 | |
| 67 | R.QYTVLDDALFK.E | ||||||||
| 74 | K.KSYFEFCENK.Y | ||||||||
| 19 (33/9.5) | PMD | XP_001651000 | AAEL000793-PA | 199 | 87 | 2/16 | 29.6/9.1 | R.MPTLVWDDELAHIASFNAR.K + Oxidation (M) | AAEL000793 |
| 112 | R.RGPHVACNAPTQFGSACGQEPK.F | ||||||||
| PMD-R | AAL76012 | Putative secreted protein | 199 | 87 | 2/16 | 29.6/9.1 | R.MPTLVWDDELAHIASFNAR.K + Oxidation (M) | AAEL000793 | |
| 112 | R.RGPHVACNAPTQFGSACGQEPK.F | ||||||||
| UPK-R | AAL76009 | Putative secreted protein | 38 | 38 | 1/3 | 30.2/9.0 | K.DYCSSVFR.K | AAEL003053 | |
| 20 (33/4.6) | PMD | AAX54871 | Putative 19.6 kDa secreted protein | 31 | 31 | 1/4 | 21.8/4.8 | K.VIEQLDQIK.V | AAEL010228 |
| PMD-R | XP_001660690 | AAEL010228-PA | 166 | 62 | 2/12 | 21.8/4.8 | K.DSNAYQCSQDR.S | AAEL010228 | |
| 104 | R.NPIVDVIGSAGDFSK.I | ||||||||
| UPK-R | XP_001660690 | AAEL010228-PA | 173 | 66 | 2/12 | 21.8/4.8 | K.DSNAYQCSQDR.S | AAEL010228 | |
| 107 | R.NPIVDVIGSAGDFSK.I | ||||||||
| 21 (31/4.1) | PMD | ABF18125 | 30 kDa salivary gland allergen variant 3 | 124 | 64 | 2/6 | 27.9/4.2 | R.VPVVEAIGR.I | AAEL010235 |
| 61 | K.NDPADTYR.Q | ||||||||
| PMD-R | ABF18125 | 30 kDa salivary gland allergen variant 3 | 452 | 64 | 6/18 | 27.9/4.2 | R.VPVVEAIGR.I | AAEL010235 | |
| 61 | R.QVVALLDKDTK.V | ||||||||
| 86 | R.SALNNDLQSEVR.V | ||||||||
| 75 | K.SEYQCSEDSFAAAK.S | ||||||||
| 80 | K.KSEYQCSEDSFAAAK.S | ||||||||
| 88 | K.KKSEYQCSEDSFAAAK.S | ||||||||
| UPK-R | ABF18125 | 30 kDa salivary gland allergen variant 3 | 301 | 61 | 4/17 | 27.9/4.2 | K.NDPADTYR.Q | AAEL010235 | |
| 62 | R.QVVALLDKDTK.V | ||||||||
| 107 | R.SALNNDLQSEVR.V | ||||||||
| 71 | K.SEYQCSEDSFAAAK.S | ||||||||
| 22 (15/9.5) | PMD | AAL16050 | Short form D7Cclu23 salivary protein | 32 | 32 | 1/6 | 18.2/9.0 | R.FFTEKPFCK.- | AAEL006423 |
| PMD-R | AAL16050 | Short form D7Cclu23 salivary protein | 163 | 47 | 4/22 | 18.2/9.1 | K.INGWAYFR.C | AAEL006423 | |
| 46 | R.FFTEKPFCK.- | ||||||||
| 54 | R.NFLCHTANFK.L | ||||||||
| 16 | K.TEMGDKINGWAYFR.C + Oxidation (M) | ||||||||
| UPK-R | AAL16050 | Short form D7Cclu23 salivary protein | 32 | 32 | 1/6 | 18.2/9.1 | R.FFTEKPFCK.- | AAEL006423 | |
| 23 (15/5.6) | PMD | AAL76029 | Putative C-type lectin | 33 | 33 | 1/6 | 18.1/5.3 | K.QQQVEELAQR.V | CTL16 |
| PMD-R | XP_001647974 | AAEL000533-PA | 87 | 46 | 2/12 | 18.1/5.3 | R.LAVLDSEQK.Q | CTL16 | |
| 40 | K.QQQVEELAQR.V | ||||||||
| UPK-R | AAL76029 | Putative C-type lectin | 93 | 51 | 2/12 | 18.1/5.3 | R.LAVLDSEEK.Q | CTL16 | |
| 42 | K.QQQVEELAQR.V | ||||||||
| 24 (15/5.9) | PMD | AAL76035 | Putative 16.9 kDa secreted protein | 135 | 23 | 3/20 | 17.4/5.5 | K.TELDEVTK.E | SG14.5sp |
| 32 | R.NLQVDGNMPK.V + Oxidation (M) | ||||||||
| 80 | K.VAQDMVPYGFNIK.T + Oxidation (M) | ||||||||
| PMD-R | ABF18031 | Short salivary D7 protein, partial | 80 | 80 | 1/8 | 17.5/5.7 | K.VAQDMVPYGFNIK.T + Oxidation (M) | na | |
| UPK-R | ABF18031 | Short salivary D7 protein, partial | 75 | 75 | 1/8 | 17.5/5.7 | K.VAQDMVPYGFNIK.T + Oxidation (M) | na | |
| A1 (20/8.6) | PMD | ABF18082 | Short D7 protein | 44 | 44 | 1/5 | 18.6/8.2 | R.QNQIEELNK.L | SG16.2sp |
| A2 (56/6.2) | PMD-R | ABF18028 | Salivary anti-FXa serpin | 229 | 70 | 3/8 | 48.3/6.1 | R.TAMAVAIGSEK.V + Oxidation (M) | SRPN23 |
| 69 | K.MEMSIAADGEK.Q + Oxidation (M) | ||||||||
| 90 | K.TPPEAAMGLEDK.Q + Oxidation (M) | ||||||||
| UPK-R | ABF18028 | Salivary anti-FXa serpin | 95 | 95 | 1/3 | 48.3/6.1 | R.IPQFGLQTTVPGR.Q | SRPN23 | |
| A4 (59/6.2) | UPK-R | ABF18509 | Salivary serpin | 235 | 62 | 3/8 | 48.2/6.3 | R.MGQVINDALK.N + Oxidation (M) | SRPN23 |
| 68 | K.TPPEAGMGLEDK.Q + Oxidation (M) | ||||||||
| 105 | R.IPQFGLQTTVPGR.Q |
aSpot number refers to those shown in Fig. 2 /(Observed MW/pI)
bAccession number of the best hit of proteins from Ae. aegypti, available at http://www.ncbi.nlm.nih.gov
cProt. Score = Protein score, Mowse score ≥ 30
dPS = Peptide score
eNo. P/%C = Number of peptide/% coverage
fName of the gene that codes for the protein sequences, available at http://www.uniprot.org/uploadlists
gna, not available
Fig. 3Differential protein expression in salivary glands between PMD and PMD-R strains. Differences in protein expression are represented as expression ratio or fold expression (PMD-R/PMD). Horizontal dot lines indicate the 2-fold difference in expression level in either direction (2 for a higher expression in the PMD-R strain and − 2 for a lower expression in the PMD-R strain). Proteins showing significantly different more than or less than 2-fold expression (Student’s t-test, P ≤ 0.05) are indicated by an asterisk (*). The ANV of each major protein and their fold expression values are shown in Additional file 3: Table S2
Fig. 4Differential protein expression in salivary glands between PMD and UPK-R strains. Differences in protein expression are represented as expression ratio or fold expression (UPK-R /PMD). Horizontal dot lines indicate the 2-fold difference in expression level in either direction (2 for a higher expression in the UPK-R strain and − 2 for a lower expression in the UPK-R strain). Proteins showing significantly different more than or less than 2-fold expression (Student’s t-test, P ≤ 0.05) are indicated by an asterisk (*). The ANV of each major protein and their fold expression values are shown in Additional file 4: Table S3
Fig. 5Differential protein expression in salivary glands between PMD-R and UPK-R strains. Differences in protein expression are represented as expression ratio or fold expression (UPK-R /PMD-R UPK-R). Horizontal dot lines indicate the 2-fold difference in expression level in either direction (2 for a higher expression in the UPK-R strain and -2 for a lower expression in the UPK-R strain). Proteins showing significantly different more than or less than 2-fold expression (Student’s t-test, P ≤ 0.05) are indicated by an asterisk (*). The ANV of each major protein and their fold expression values are shown in Additional file 5: Table S4
Fig. 6Representative functional associations of salivary gland proteins of adult female Ae. aegypti between PMD, PMD-R, and UPK-R strains with other proteins, chemicals and insecticide using the STITCH database 5.0. The predicted functional interaction networks are shown in the network view where the stronger associations are represented by thicker lines. Protein-protein interactions are shown in grey, chemical-protein interactions in green and interactions between chemicals in red. Gene names corresponding to the proteins are described in Table 2
Fig. 7Representative functional association of the SRPN23 with pyrethroid insecticide using the STITCH database 5.0. The predicted functional interaction networks are shown in the network view where the stronger associations are represented by thicker lines. Protein-protein interactions are shown in grey, chemical-protein interactions in green and interactions between chemicals in red. Gene names corresponding to the protein are described in Table 2